Jim Cramer Says Vertex Doing ‘Lord’s Work’: Can Q3 Earnings Outshine Bearish Charts? – Vertex Prescription drugs (NASDAQ:VRTX)

Vertex Prescription drugs Inc VRTX can be reporting its third-quarter earnings on Monday. Wall Avenue expects $4.14 in EPS and $2.72 billion in revenues as the corporate stories after market hours.

Jim Cramer is not holding again on Vertex inventory calling it a purchase and lauding its work as “doing the lord’s work” on CNBC’s Mad Cash Lightning Spherical. Cramer’s endorsement provides to investor intrigue as Vertex prepares to launch its third-quarter earnings. The inventory is up 22.13% over the previous 12 months and 14.65% YTD.

Let’s have a look at what the charts point out for Vertex inventory and the way the inventory at the moment maps towards Wall Avenue estimates.

Learn Additionally: Cathie Wooden Says Trump’s Concepts On Eliminating Earnings Tax And Imposing Tariffs Brings Again Vibes Of ‘Early Days Of Our Nation’

Vertex Chart Faces A Strongly Bearish Pattern Forward Of Q3 Earnings…

Vertex inventory at the moment faces a strongly bearish pattern, with its $471.12 share worth trailing its 5, 20 and 50-day Exponential Transferring Averages (EMA).

Chart created utilizing Benzinga Professional

This bearish momentum is bolstered as VRTX trades beneath key short-term Easy Transferring Averages (SMA): the eight-day SMA at $473.57, the 20-day SMA at $475.65, and the 50-day SMA at $474.24—all signaling bearish stress.

Nevertheless, a longer-term bullish undertone is clear, with the 200-day SMA at $450.72 suggesting assist.

The Transferring Common Convergence Divergence (MACD) indicator sits at 0.39, offering a bullish sign, whereas the Relative Power Index (RSI) at 47.44 hints at balanced momentum. Regardless of the short-term bearish setup, these combined indicators point out slight shopping for stress that might assist VRTX in the long term.

But Vertex Analysts See 22% Upside

Scores & Consensus Estimates: The consensus analyst score on Vertex inventory stands at a Purchase with a worth goal of $502.08. The newest analyst rankings from Oppenheimer, HC Wainwright & Co. and UBS in October, set a median worth goal of $567.33 for Vertex inventory, suggesting a 22.33% upside.

With combined technical indicators, Vertex’s third quarter outcomes might be the deciding issue on this tug-of-war between Cramer’s confidence and the bearish charts. As Cramer’s bullish name units the tone, all eyes are on Vertex to see if its earnings report can ship the efficiency buyers—and the charts—are ready for.

VRTX Worth Motion: Vertex inventory closed the buying and selling day Friday at $472.12, down 1.02%.

Learn Subsequent:

Picture: Shutterstock